<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Taba">
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td align="left">An effective pharmacovigilance system requires partnership between multiple stakeholders, including national regulatory authorities (NRAs) and marketing authorisation holders, to achieve public health goals.</td>
   </tr>
   <tr>
    <td align="left">As countries further enhance their pharmacovigilance systems, consideration needs to be given to the development of requirements that benefit patients, are well thought and are practical to implement.</td>
   </tr>
   <tr>
    <td align="left">With an understanding of global pharmacovigilance systems and stakeholders, and local pharmacovigilance needs, pharmacovigilance experts from innovator pharmaceutical companies propose recommendations for consideration by NRAs as they further develop pharmacovigilance requirements in their country.</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
